Please enable JavaScript to continue using this application.

Compare $NERV vs $NKTX | Chartloom

Compare

$NERV vs $NKTX

Minerva Neurosciences Inc · Nkarta Inc

NERV

Minerva Neurosciences Inc

NKTX

Nkarta Inc

Compare $NERV vs $NKTX

Comparing Minerva Neurosciences Inc and Nkarta Inc

NERVMinerva Neurosciences Inc

NKTXNkarta Inc

NERVMinerva Neurosciences Inc

Market cap

$148M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-18.9%

52W performance

12.4%

FCF yield

-17.7%

NKTXNkarta Inc

Market cap

$161M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

20.3%

52W performance

7.7%

FCF yield

-58.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NERV

NKTX

Detailed metrics comparison

NERV

Minerva Neurosciences Inc

NKTX

Nkarta Inc

Market Cap

NERV$148M

NKTX$161M

Enterprise Value

NERV$184M

NKTX$136M

Price

NERV$3.18

NKTX$2.25

P/E Ratio

NERVN/A

NKTXN/A

P/S Ratio

NERV0.00x

NKTX0.00x

EV/Sales

NERV0.00x

NKTX0.00x

EV/EBITDA

NERV28.95x

NKTX0.00x

P/B Ratio

NERV19.58x

NKTX0.74x

P/FCF Ratio

NERVN/A

NKTXN/A

EV/FCF

NERV-7.01x

NKTX-1.45x

PEG Ratio

NERVN/A

NKTXN/A

Forward P/E (NTM)

NERVN/A

NKTXN/A

Forward P/S (NTM)

NERVN/A

NKTXN/A

Revenue (TTM)

NERV$0

NKTX$0

Revenue Growth (YoY)

NERVN/A

NKTXN/A

Forward Rev Growth

NERV534.2%

NKTX2561.2%

Gross Margin (TTM)

NERV0.0%

NKTX0.0%

Operating Margin (TTM)

NERV0.0%

NKTX0.0%

EBITDA Margin (TTM)

NERV0.0%

NKTX0.0%

Net Margin (TTM)

NERV0.0%

NKTX0.0%

FCF Margin (TTM)

NERVN/A

NKTXN/A

Net Income (TTM)

NERV$-395M

NKTX$-117M

FCF (TTM)

NERV$-26M

NKTX$-94M

EPS (TTM)

NERV-$5.00

NKTX-$1.57

ROE (TTM)

NERV-16962.0%

NKTX-3964.0%

ROA (TTM)

NERV-50048.0%

NKTX-3045.0%

ROIC (TTM)

NERV-16962.0%

NKTX-3964.0%

Cash

NERV$25M

NKTX$25M

Debt

NERV$60M

NKTX$0

Net Cash/Debt

NERV$-35M

NKTX$25M

Current Ratio (TTM)

NERV20.14x

NKTX7.98x

Quick Ratio (TTM)

NERV19.04x

NKTX7.76x

Debt/Equity (TTM)

NERV0.00x

NKTX0.00x

Debt/Assets (TTM)

NERV0.0%

NKTX0.0%

Interest Coverage (TTM)

NERVN/A

NKTXN/A

Net Debt/EBITDA (TTM)

NERV0.00x

NKTX0.00x

Beta

NERV0.04

NKTX1.19

52W Performance

NERV12.4%

NKTX7.7%

YTD Performance

NERV-18.9%

NKTX20.3%

% from 52W High

NERV-74.5%

NKTX-39.5%

% from 52W Low

NERV42.1%

NKTX32.4%

Asset Turnover (TTM)

NERV0.00x

NKTX0.00x

FCF Yield (TTM)

NERV-17.7%

NKTX-58.3%

Earnings Yield (TTM)

NERV-266.7%

NKTX-72.9%

Dividend Yield (TTM)

NERVN/A

NKTXN/A

Rule of 40

NERV0.0

NKTX0.0

EV/GP/RG

NERVN/A

NKTXN/A

Ticker research

View NERV research View NKTX research

Metric	NERV Minerva Neurosciences Inc	NKTX Nkarta Inc
Market & Valuation
Market Cap	$148M	$161M
Enterprise Value	$184M	$136M
Price	$3.18	$2.25
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	28.95x	0.00x
P/B Ratio	19.58x	0.74x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.01x	-1.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	534.2%	2561.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-395M	$-117M
FCF (TTM)	$-26M	$-94M
EPS (TTM)	-$5.00	-$1.57
ROE (TTM)	-16962.0%	-3964.0%
ROA (TTM)	-50048.0%	-3045.0%
ROIC (TTM)	-16962.0%	-3964.0%
Financial Health
Cash	$25M	$25M
Debt	$60M	$0
Net Cash/Debt	$-35M	$25M
Current Ratio (TTM)	20.14x	7.98x
Quick Ratio (TTM)	19.04x	7.76x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.04	1.19
52W Performance	12.4%	7.7%
YTD Performance	-18.9%	20.3%
% from 52W High	-74.5%	-39.5%
% from 52W Low	42.1%	32.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-17.7%	-58.3%
Earnings Yield (TTM)	-266.7%	-72.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View NERV research	View NKTX research

Valuation

P/S Ratio

NERV

0.00x

NKTX

0.00x

EV/FCF

NERV

-7.01x

NKTX

-1.45x

Growth & revenue

Forward Revenue Growth

NKTX

2561.2%

NERV

534.2%

Profitability & performance

Gross Margin

NERV

0.0%

NKTX

0.0%

ROE

NKTX

-3964.0%

NERV

-16962.0%

FCF Yield %

NERV

-17.7%

NKTX

-58.3%

52-Week Performance

NERV

12.4%

NKTX

7.7%

Detailed metrics comparison

NERV

Minerva Neurosciences Inc

NKTX

Nkarta Inc

Market Cap

NERV$148M

NKTX$161M

Enterprise Value

NERV$184M

NKTX$136M

Price

NERV$3.18

NKTX$2.25

P/E Ratio

NERVN/A

NKTXN/A

P/S Ratio

NERV0.00x

NKTX0.00x

EV/Sales

NERV0.00x

NKTX0.00x

EV/EBITDA

NERV28.95x

NKTX0.00x

P/B Ratio

NERV19.58x

NKTX0.74x

P/FCF Ratio

NERVN/A

NKTXN/A

EV/FCF

NERV-7.01x

NKTX-1.45x

PEG Ratio

NERVN/A

NKTXN/A

Forward P/E (NTM)

NERVN/A

NKTXN/A

Forward P/S (NTM)

NERVN/A

NKTXN/A

Revenue (TTM)

NERV$0

NKTX$0

Revenue Growth (YoY)

NERVN/A

NKTXN/A

Forward Rev Growth

NERV534.2%

NKTX2561.2%

Gross Margin (TTM)

NERV0.0%

NKTX0.0%

Operating Margin (TTM)

NERV0.0%

NKTX0.0%

EBITDA Margin (TTM)

NERV0.0%

NKTX0.0%

Net Margin (TTM)

NERV0.0%

NKTX0.0%

FCF Margin (TTM)

NERVN/A

NKTXN/A

Net Income (TTM)

NERV$-395M

NKTX$-117M

FCF (TTM)

NERV$-26M

NKTX$-94M

EPS (TTM)

NERV-$5.00

NKTX-$1.57

ROE (TTM)

NERV-16962.0%

NKTX-3964.0%

ROA (TTM)

NERV-50048.0%

NKTX-3045.0%

ROIC (TTM)

NERV-16962.0%

NKTX-3964.0%

Cash

NERV$25M

NKTX$25M

Debt

NERV$60M

NKTX$0

Net Cash/Debt

NERV$-35M

NKTX$25M

Current Ratio (TTM)

NERV20.14x

NKTX7.98x

Quick Ratio (TTM)

NERV19.04x

NKTX7.76x

Debt/Equity (TTM)

NERV0.00x

NKTX0.00x

Debt/Assets (TTM)

NERV0.0%

NKTX0.0%

Interest Coverage (TTM)

NERVN/A

NKTXN/A

Net Debt/EBITDA (TTM)

NERV0.00x

NKTX0.00x

Beta

NERV0.04

NKTX1.19

52W Performance

NERV12.4%

NKTX7.7%

YTD Performance

NERV-18.9%

NKTX20.3%

% from 52W High

NERV-74.5%

NKTX-39.5%

% from 52W Low

NERV42.1%

NKTX32.4%

Asset Turnover (TTM)

NERV0.00x

NKTX0.00x

FCF Yield (TTM)

NERV-17.7%

NKTX-58.3%

Earnings Yield (TTM)

NERV-266.7%

NKTX-72.9%

Dividend Yield (TTM)

NERVN/A

NKTXN/A

Rule of 40

NERV0.0

NKTX0.0

EV/GP/RG

NERVN/A

NKTXN/A

Ticker research

View NERV research View NKTX research

Metric	NERV Minerva Neurosciences Inc	NKTX Nkarta Inc
Market & Valuation
Market Cap	$148M	$161M
Enterprise Value	$184M	$136M
Price	$3.18	$2.25
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	28.95x	0.00x
P/B Ratio	19.58x	0.74x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.01x	-1.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	534.2%	2561.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-395M	$-117M
FCF (TTM)	$-26M	$-94M
EPS (TTM)	-$5.00	-$1.57
ROE (TTM)	-16962.0%	-3964.0%
ROA (TTM)	-50048.0%	-3045.0%
ROIC (TTM)	-16962.0%	-3964.0%
Financial Health
Cash	$25M	$25M
Debt	$60M	$0
Net Cash/Debt	$-35M	$25M
Current Ratio (TTM)	20.14x	7.98x
Quick Ratio (TTM)	19.04x	7.76x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.04	1.19
52W Performance	12.4%	7.7%
YTD Performance	-18.9%	20.3%
% from 52W High	-74.5%	-39.5%
% from 52W Low	42.1%	32.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-17.7%	-58.3%
Earnings Yield (TTM)	-266.7%	-72.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View NERV research	View NKTX research